Key Figures (£ million)Half year ended 31.120202019[\*](#tbl8fn1){ref-type="table-fn"}Revenue12401143Of Which:John Crane474449Cost of Sales731652Gross Profit509491Sales & Distribution Costs138130Admin Expenses226234Operating Profit145127Of Which:John Crane9494Profit before Income Tax (Continuing Ops)4689Profit from Discontinued Operations13367Profit for the Period attributable to Smiths145121[^1]Source: Smiths half year 2020 results.

COMMENTSmiths Group has posted revenues from continuing operations for its first half-year of fiscal 2020 of £1.2 billon, up 8.5% on the corresponding prior year period.The company reported that underlying revenue growth contributed approximately three percentage points of the upturn, with the remainder coming from acquisitions. Smiths reported strong growth across its John Crane, Smiths Detection and Flex-Tek operations, held back by market weakness in Smiths Interconnect. In terms of Covid-19 impact, the company said that only the Chinese operations of John Crane and Interconnect were disrupted during the reporting period, although this had subsequently widened with impact on both demand and supply expected in the near-term.John Crane\'s sales were up 5.6% at £474 million, all of which was attributed to underlying growth. The division reported that revenue in its Energy segment and original equipment were up around 11% and 8% respectively, while they fell 2% for Industrial activities due to a strong comparator and the phasing of orders.Smiths also enjoyed good growth in profitability for the period with its statutory operating profit increasing 14.2% to £145 million. Its net profit, which included a £133 million contribution from discontinued operations, was up 19.8% to also reach £145 million."We started the year strongly, delivering good growth and cash across the group," Smiths' CEO, Andy Reynolds Smith, said. "This positive start has also continued during the first two months of the second half, demonstrating the quality and financial strength of our business."Smith said the company was confident of its resilience and preparedness to meet the Covid challenge. "We have clear plans underway to contain costs, flex our operations, maximise business continuity and conserve cash," he said.[www.smiths.com](http://www.smiths.com){#interrefs10}

[^1]: Restated with Smiths Medical as a discontinued operation.
